Total number of shares and voting rights in Zealand Pharma at September 29, 2023
29 September 2023 - 5:15PM
Total number of shares and voting rights in Zealand Pharma at
September 29, 2023
Company announcement – No. 36 / 2023
Total number of shares and voting rights in Zealand
Pharma at September 29, 2023
Copenhagen, Denmark, September 29, 2023 –
Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50
78), a Copenhagen-based biotechnology company focused on the
discovery and development of innovative peptide-based medicines, in
accordance with section 32 of the Danish Capital Markets Act,
announces the total number of shares and voting rights in the
Company at the end of a calendar month during which there have been
changes to its share capital.
In Company announcement No. 34/2023 from September 14, 2023,
Zealand announced an increase in share capital relating to exercise
of employee warrants. Following these announcements, the table
below lists the total number of shares and voting rights in Zealand
up to and including September 29, 2023.
Date |
Number of shares(nominal value of DKK 1
each) |
Share capital(nominal value in
DKK) |
Number of voting rights |
September 29, 2023 |
58,677,438 |
58,677,438 |
58,677,438 |
# # #
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology
company focused on the discovery and development of peptide-based
medicines. More than 10 drug candidates invented by Zealand have
advanced into clinical development, of which two have reached the
market and three candidates are in late-stage development. The
company has development and partnerships with a number of blue-chip
pharma companies as well as commercial partnerships for its
marketed products.
Zealand was founded in 1998 and is headquartered in Copenhagen,
Denmark, with a presence in the U.S. that includes Boston. For more
information about Zealand’s business and activities, please
visit www.zealandpharma.com.
Contact:
Adam Lange (Investors) Investor Relations Officer Zealand
Pharma akl@zealandpharma.com |
Anna Krassowska, PhD (Investors and Media) Vice President,
Investor Relations & Corporate Communications Zealand Pharma
ank@zealandpharma.com |
Zealand Pharma AS (TG:22Z)
Historical Stock Chart
Von Mai 2024 bis Jul 2024
Zealand Pharma AS (TG:22Z)
Historical Stock Chart
Von Jul 2023 bis Jul 2024